Dr. Martens plc (LON:DOCS)

London flag London · Delayed Price · Currency is GBP · Price in GBX
90.45
-1.10 (-1.20%)
Oct 9, 2025, 4:36 PM BST
-1.20%
Market Cap884.74M
Revenue (ttm)787.60M
Net Income (ttm)4.50M
Shares Out966.40M
EPS (ttm)0.00
PE Ratio195.79
Forward PE21.48
Dividend0.03 (2.79%)
Ex-Dividend DateAug 28, 2025
Volume925,210
Average Volume2,297,294
Open88.70
Previous Close91.55
Day's Range88.60 - 93.55
52-Week Range43.02 - 100.87
Beta0.24
RSI50.58
Earnings DateNov 20, 2025

About Dr. Martens

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]

Founded 1945
Employees 2,348
Stock Exchange London Stock Exchange
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2024, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.

Financial Statements

News

Dr. Martens: Iconic Brand At A Potential Bargain

Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a con...

4 months ago - Seeking Alpha

Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript

Dr. Martens plc (OTCPK:DOCMF) Q4 2025 Earnings Conference Call June 5, 2025 2:00 AM ET Company Participants Giles Wilson - CFO & Director Onyeije Ogueri Nwokorie - CEO & Chief Brand Officer Onyeije Og...

4 months ago - Seeking Alpha

Dr Martens forecasts return to profit growth, shares jump

British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...

4 months ago - Reuters

Dr. Martens Selects Amperity to Transform Customer Data Strategy

LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...

7 months ago - Business Wire

Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript

Dr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie - CEO Giles Wilson - CFO Conference Call Participants Kate Calvert - I...

9 months ago - Seeking Alpha

Dr Martens' shares jump 15% on new CEO's start date despite drop in first half sales

Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker

11 months ago - Market Watch

Dr Martens sees strong US holiday sales, cuts inventory and debt

Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...

11 months ago - Reuters

Stock Picks From Seeking Alpha's October 2024 New Analysts

In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...

11 months ago - Seeking Alpha

Dr. Martens: Struggling To See The Downside At This Valuation

Dr. Martens is a strong brand with healthy cash flows and a cheap valuation, making it an attractive investment opportunity. Growth potential lies in geographic expansion and product line diversificat...

1 year ago - Seeking Alpha

Dr. Martens shares plunge to record lows on discount bulk sale via Goldman Sachs

Dr. Martens' investors sold 70 million shares in the bootmaker at a price of 57.85 pence per share, in what marks a 10% discount on its closing share price on Thursday

1 year ago - Market Watch

Dr. Martens plc. (DOCMF) H2 2024 Earnings Call Transcript

Dr. Martens plc. (OTCPK:DOCMF) H2 2024 Earnings Conference Call May 30, 2024 4:30 AM ET Corporate Participants Kenneth Wilson - Chief Executive Officer Giles Wilson - Chief Financial Officer Conferenc...

1 year ago - Seeking Alpha

Dr Martens will cut up to £25m in costs to counter weak US sales

British footwear brand does not rule out job losses, while profits fall by 43% to £97m

1 year ago - The Guardian

Dr. Martens Stock Plummets on Downbeat US Outlook

U.K.-listed Dr. Martens PLC issued a downbeat outlook for its U.S. sales on Tuesday, noting that it expects wholesale revenue in the country to be down by double digits for its fiscal 2025 year, and s...

1 year ago - Investopedia

Dr. Martens' profit warning highlights U.S. consumer-confidence challenge

Dr. Martens' profit warning sent shares of the iconic shoe brand tumbling Tuesday and spotlighted consumer-spending challenges on both sides of the Atlantic.

1 year ago - Market Watch

Dr. Martens Shares Tumble as Bootmaker Warns of Tough Year

Dr. Martens shares plummeted after the iconic British footwear and clothing brand said Chief Executive Officer Kenny Wilson plans to step down and warned of a challenging year ahead.

1 year ago - WSJ

Dr. Martens shares lose a third of their value on U.S. warning

Shares of iconic shoe brand Dr. Martens fell as much as 32% on Tuesday with the company's U.S. business going so badly it needs to extend paying for additional storage space as it announced its chief ...

1 year ago - Market Watch

Dr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlook

Shares of Dr. Martens plunged to a record low in early deals after the shoemaker flagged a challenging 2025 outlook.

1 year ago - CNBC

Bootmaker Dr Martens names new CEO, flags tough year on weak demand

British bootmaker Dr Martens named its chief brand officer Ije Nwokorie as its next CEO on Tuesday, saying Kenny Wilson had decided this year would be his final year as top boss.

1 year ago - Reuters

Exclusive: Marathon Partners pushes Dr. Martens for strategic review, possible sale

Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to ...

1 year ago - Reuters

Dr. Martens: A Value Play With High Yield Worth Digging Into

Dr. Martens aims to become a £2 billion revenue company by focusing on direct-to-consumer sales, global expansion, and increasing online sales. The company has a strong brand with steady brand awarene...

1 year ago - Seeking Alpha

Dr. Martens' Headwinds Have Created An Undervalued Growth Story

Dr. Martens' stock has lost the majority of its value as economic headwinds have halted the company's growth for the time being. The company continues to have quite strong margins, and I believe the l...

1 year ago - Seeking Alpha

Dr Martens' revenue plummets by a fifth as US sales plunge

Bootmaker says global sales fell by 18%, with cash-strapped consumers refusing to splash out at Christmas

1 year ago - The Guardian

Bootmaker Dr Martens hit by weak December as US sales slide

Britain's Dr Martens said its visibility over wholesale orders "remains weak" as the bootmaker posted a drop in third-quarter revenue on Thursday following several profit warnings and a disappointing ...

1 year ago - Reuters

Dr. Martens: Don't Miss This Opportunity

Dr. Martens stock has plummeted over 80% since its IPO in early 2021, but the company's earnings and financials remain strong. H1 FY2024 disappointed, but long-term growth remains. The company is unde...

2 years ago - Seeking Alpha

Dr. Martens plc. (DOCMF) H1 2024 Earnings Call Transcript

Dr. Martens plc. (OTCPK:DOCMF) H1 2024 Earnings Conference Call November 30, 2023 3:30 AM ET Company Participants Bethany Barnes - Head of Investor Relations Kenneth Wilson - Chief Executive Officer P...

2 years ago - Seeking Alpha